aTyr Pharma | LIFE - Operating Profit


aTyr Pharma reported $-26.74M in Operating Profit for its fiscal quarter ending in September of 2025.





Operating Profit Change Date
Alterity Therapeutics Limited AUD -7.77M 2.99M Jun/2023
Ardelyx USD 4.67M 19.07M Sep/2025
aTyr Pharma USD -26.74M 6.43M Sep/2025
Biogen USD 659.6M 192.2M Sep/2025
Bristol-Myers Squibb USD 4.2B 562M Dec/2025
Cipla INR 9.77B 6.21B Dec/2025
Clal Biotechnology ILS -1.74M 7.46M Dec/2022
Compugen USD -7.89M 540K Sep/2025
CSL USD 2.64B 1.97B Dec/2025
Curis USD -12.51M 40K Jun/2024
Galapagos EUR 780.56M 822.23M Dec/2025
GlaxoSmithKline GBP 1.44B 1.35B Dec/2025
Grifols EUR 411.56M 15.51M Sep/2025
Novartis USD 4.5B 363M Sep/2025
Roche Holding CHF 9.56B 3.8B Dec/2025
United Therapeutics USD -14.6M 403.9M Dec/2025
Xoma USD -15.64M 5.56M Sep/2024